Bromocriptine mesylate
Tocris Bioscience | Catalog # 0427
Key Product Details
Description
Product Description
Bromocriptine mesylate is a selective D3 and D2 dopamine receptor agonist (Ki values are ~ 5 nM and ~ 8 nM respectively). Activates both isoforms of D2 receptor (EC50 values are 0.10-0.12 nM and 4.4 nM for D2L and D2S receptors, respectively. Bromocriptine shows anti-Aβ effects that are increased in combination with Cromolyn (Cat. No. 6424) and Topiramate (Cat. No. 3620). Also lowers glucose and increases insulin sensitivity in vivo.
Product Specifications for Bromocriptine mesylate
Molecular Weight
Formula
Storage
Purity
Chemical Name
CAS Number
PubChem ID
InChI Key
SMILES
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 75.07 | 100 |
Preparing Stock Solutions for Bromocriptine mesylate
The following data is based on the product molecular weight 750.70.
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.33 mL | 6.66 mL | 13.32 mL |
| 5 mM | 0.27 mL | 1.33 mL | 2.66 mL |
| 10 mM | 0.13 mL | 0.67 mL | 1.33 mL |
| 50 mM | 0.03 mL | 0.13 mL | 0.27 mL |
Calculators
Background References
References are publications that support the biological activity of the product. See our Citations tab to view 31 publications citing the usage of this product.
- Tavares Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes. Mol.Metab. 2021 PMID: 33933677
- Kondo iPSC-based compound screening and in vitro trials identify a synergistic anti-amyloid β combination for Alzheimer's disease. Cell Rep. 2017 PMID: 29166618
- Traub The effects of chronic bromocri. treatment on behaviour and DA receptor binding in the rat striatum. Eur.J.Pharmacol. 1985 PMID: 3936723
- Seeman and Van Tol DA receptor pharmacology. TiPS 1994 PMID: 7940991
- Lieberman and Goldstein Bromocriptine in Parkinson disease. Pharmacol.Rev. 1985 PMID: 3901046
- Aubner Bromocriptine produces decreases in cocaine self-administration in the rat. Neuropsychopharmacology 1990 PMID: 2317262
Product Documents for Bromocriptine mesylate
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for Bromocriptine mesylate
For research use only
Citations for Bromocriptine mesylate
Customer Reviews for Bromocriptine mesylate
There are currently no reviews for this product. Be the first to review Bromocriptine mesylate and earn rewards!
Have you used Bromocriptine mesylate?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review